Looking Ahead to the Next Generation of Malaria Tools
Malaria kills around 600,000 people annually, most of them young children in Africa. Preventing malaria has long been a focus of GiveWell’s grantmaking, primarily through two proven interventions: insecticide-treated nets, which protect people while they’re sleeping, and seasonal malaria chemoprevention (SMC), which provides preventive antimalarial medicine to young children during the months when malaria transmission is highest.
As our Malaria team has grown and specialized, we’ve been able to expand beyond those two interventions. To make more progress against this disease, we recently announced plans to further scale our malaria grantmaking. As part of that effort, we’re funding monitoring and evaluation, as well as other research, to learn more about the effectiveness and potential harms of newer strategies for preventing and treating malaria. This work will help us prepare to fund the scale-up of promising and cost-effective programs in the years ahead.
In this episode, GiveWell co-founder and CEO Elie Hassenfeld speaks with three members of our Malaria research team—Senior Researcher James Watson, Senior Researcher Lucy McNamara, and Senior Program Officer Rosie Bettle—about new tools that could help prevent or treat malaria in the future.
Elie, Lucy, Rosie, and James discuss:
- Building evidence on spatial emanators: Spatial emanators are small plastic sheets hung inside homes that release insecticide to repel and kill mosquitoes. Unlike insecticide-treated nets, which protect people as they sleep, spatial emanators protect people whenever they’re indoors. While there are a number of randomized controlled trials (RCTs) of spatial emanators, only two trials assessing the ability of these devices to prevent malaria took place in Africa, where malaria burden is highest. One, conducted in Kenya, found that they reduced malaria infections by about one-third; the other, in Mali, found no effect, though that trial faced some challenges and was unable to achieve high coverage. We’re funding monitoring and evaluation of pilot implementation of spatial emanators alongside nets in Burkina Faso, Sierra Leone, and the Democratic Republic of the Congo (DRC) to learn more about their effectiveness, how many people they reach, and whether they impact net use. If the evidence holds up, emanators could be a highly cost-effective way to protect people, including where living situations make it harder to hang sleeping nets.
- Speeding up research on insecticide-treated baby wraps: In many African countries, mothers carry infants and young children on their backs in cloth wraps. Treating the wraps with insecticide could provide protection from mosquito bites during a period when children are particularly vulnerable to die from malaria. An RCT in Uganda found that wraps treated with permethrin, an insecticide extensively used to treat bed nets, reduced malaria illness by about two-thirds. However, in this trial the baby wraps were retreated every month, and real-world settings are unlikely to achieve this level of adherence. Long-lasting factory-treated wraps are a more promising option, so we recently funded a trial in DRC of two insecticides for factory-treated wraps designed to last for up to a year. Positive results could support a change in World Health Organization guidance and lead to broader adoption.
- Exploring other tools at earlier stages: We’re looking at several different tools in earlier stages of development or which have not yet been widely adopted. Malaria gene drives are one of these tools. They genetically modify mosquitoes so they’re less likely to transmit malaria—such as by reducing fertility to reduce the overall mosquito population. To facilitate the future rollout of gene drives, we’re exploring opportunities to strengthen countries’ capacity to evaluate the potential use of gene drives and helping communities get accurate information. Antimalarial suppositories are another tool in an earlier stage. Children with severe malaria who are too sick to swallow pills currently have to travel to a hospital to receive injections or IV treatment, delaying life-saving treatment. Community health workers could provide treatment more quickly with antimalarial suppositories, but they have not yet been widely adopted. We’re considering ways to strengthen community health worker systems to improve access to treatment for malaria and other childhood illnesses, which would reduce geographic and financial barriers to care.
Each of these tools could expand the range of highly cost-effective malaria programs we're able to fund in the years ahead, but some are still far from being delivered at scale. Alongside our continued support for proven programs like nets and SMC, we are working to better understand the evidence for new tools and their cost-effectiveness, alongside their potential harms and barriers to delivery. With this information, we will be better positioned to direct donors’ funds to the programs where we believe they can do the most good.
Read more about how our malaria research is growing. Visit our All Grants Fund page to learn more about how you can support this work, and listen or subscribe to our podcast for our latest updates.
This episode was recorded on November 13, 2026, and represents our best understanding at that time.
